The Cooperative Trials Group for Neuro-Oncology (COGNO) was established in 2007, following identification of a need to develop a central mechanism enabling a coordinated, structured approach to the management of large scale multi-centred neuro-oncology trials.
COGNO is a member of the Cooperative Clinical Trials Groups of the Clinical Oncological Society of Australia (COSA) and has a close working relationship with the COSA Neuro-Oncology Group. COGNO is funded by Cancer Australia. The group is located at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (CTC), at the University of Sydney. The NHMRC CTC coordinates the trials activity within COGNO.
COGNO's main aim is to conduct investigator-initiated and collaborative group trials addressing important clinical questions in patients with brain tumours.
Interview with COGNO's 800th Member
COGNO has reached an important milestone, celebrating its 800th member! To mark this special occasion, COGNO Chair Associate Professor Eng-Siew Koh, has a "Q&A" session with Dr Peter Lau, Medical Oncologist from Sir Charles Gairdner Hospital, WA.
Watch the 10 minute interview here.
Donations
Brain cancer patients are in desperate need of major research breakthroughs, yet brain cancer remains one of the most underfunded and under researched of all the cancer groups.
Your donation will help COGNO bring clinical trials to more people with brain cancer. Online donations can be made via https://www.braincancercollective.com.au/donations_cogno
Ideas or Concepts
COGNO is interested in developing new concepts into protocols and translating these into clinical research.
If you have a concept you are interested in developing, please complete this online form.
|